Thushara Galbadage

Dr. Thushara Galbadage

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2020 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
TGThushara Galbadage
Thushara Galbadage
BPBrent M. Peterson
Brent M. Peterson
JAJoseph Awada
Joseph Awada
ABAlison S. Buck
Alison S. Buck
DRDanny A. Ramirez
Danny A. Ramirez
RGRichard S. Gunasekera
Richard S. Gunasekera
To successfully mitigate the extraordinary devastation caused by the Coronavirus disease 2019 (COVID-19) pandemic, it is crucial to identify important risk factors for this disease. One such neglected health determinant is the sex of the patient. This is an essential clinical characteristic, as it can factor into a patient's clinical management and preventative measures. Some clinical studies have shown disparities in the proportion between males and females that have more severe clinical outcomes or, subsequently, die from this disease. However, this association has not been unequivocally established. Thus, the purpose of this investigation was to examine the association between male sex and COVID-19 severity. We systematically reviewed the literature, identified studies that matched predetermined selection criteria, and performed a meta-analysis to evaluate the proportion of males among four disease severity categories. Appropriate assessment strategies were implemented to assess and minimize potential biases. The results of this meta-analysis indicated that males constituted a significantly higher proportion of those who had adverse clinical outcomes and died from COVID-19. As the coronavirus spread from the East to the West, male sex remained a consistent risk factor. Our results support the establishment of the male sex as an important risk factor for this disease. Early identification and appropriate medical care for males with lab-confirmed COVID-19 may substantially change the course of clinical prognosis, resulting in greater numbers of lives saved.

24 April 2020 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
TGThushara Galbadage
Thushara Galbadage
BPBrent M. Peterson
Brent M. Peterson
RGRichard S. Gunasekera
Richard S. Gunasekera
Does COVID-19 Spread Through Droplets Alone?

9 December 2019 in ACS Nano
Verified
Journal Article
Open access
TGThushara Galbadage
Thushara Galbadage
DLDongdong Liu
Dongdong Liu
LALawrence B. Alemany
Lawrence B. Alemany
RPRobert Pal
Robert Pal
JTJames Tour
James Tour
JCJeffrey D Cirillo
Jeffrey D Cirillo
Multidrug-resistance in pathogenic bacteria is an increasing problem in patient care and public health. Molecular nanomachines (MNM) have the ability to open cell membranes using nanomechanical action. We hypothesized that MNM could be used as antibacterial agents by drilling into bacterial cell walls and increasing susceptibility of drug resistant bacteria to recently ineffective antibiotics. We exposed extensively drug resistant K. pneumoniae to light-activated MNM and found that MNM increase susceptibility to meropenem. MNM with meropenem can effectively kill K. pneumoniae that are considered meropenem resistant. We examined the mechanisms of MNM action using permeability assays and transmission electron microscopy, finding that MNM disrupt the cell wall of extensively drug resistant K. pneumoniae, exposing the bacteria to meropenem. These observations suggest that MNM could be used to make conventional antibiotics more efficacious against multidrug-resistant pathogens.

17 November 2020 in Frontiers in Psychology
Verified
Journal Article
Open access
PDF file
TGThushara Galbadage
Thushara Galbadage
BPBrent M. Peterson
Brent M. Peterson
DWDavid C. Wang
David C. Wang
JWJeffrey S. Wang
Jeffrey S. Wang
RGRichard S. Gunasekera
Richard S. Gunasekera
Critically ill patients with the Coronavirus disease 2019 (COVID-19) are dying in isolation without the comfort of their family or other social support in unprecedented numbers. Recently, healthcare teams at COVID-19 epicenters have been inundated with critically ill patients. Patients isolated for COVID-19 have had no contact with their family or loved ones and may have likely experienced death without closure. This situation highlights concerns about patients’ psychological and spiritual well-being with COVID-19 and their families, as they permanently part ways. While palliative care has advanced to adequately address these patients’ needs, the COVID-19 pandemic presents several barriers that force healthcare teams to deprioritize these essential aspects of patient care. The severe acute respiratory syndrome (SARS) outbreak in 2003 gave us a glimpse of these challenges as these patients were also isolated in hospitals. Here, we discuss the importance of the biopsychosocial spiritual model in end-of-life care and its implications on patients dying with COVID-19. Furthermore, we outline an integrative approach to address the unique and holistic needs of critically ill patients dying with COVID-19. These include intentional and increased coordination with trained palliative care staff, early and frequent goals of care including discussion of end-of-life plans, broader use of technology to improve connectedness, and shared decision making with patients’ families.

30 May 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NWNolan C. Worstell
Nolan C. Worstell
ASAkshi Singla
Akshi Singla
PSPanatda Saenkham
Panatda Saenkham
TGThushara Galbadage
Thushara Galbadage
PSPreeti Sule
Preeti Sule
HWHung-Jen Wu
Hung-Jen Wu
A single glycan-lectin interaction is often weak and semi-specific. Multiple binding domains in a single lectin can bind with multiple glycan molecules simultaneously, making it difficult for the classic “lock-and-key” model to explain these interactions. We demonstrated that hetero-multivalency, a homo-oligomeric protein simultaneously binding to at least two types of ligands, influences LecA (a Pseudomonas aeruginosa adhesin)-glycolipid recognition. We also observed enhanced binding between P. aeruginosa and mixed glycolipid liposomes. Interestingly, strong ligands could activate weaker binding ligands leading to higher LecA binding capacity. This hetero-multivalency is probably mediated via a simple mechanism, Reduction of Dimensionality (RD). To understand the influence of RD, we also modeled LecA’s two-step binding process with membranes using a kinetic Monte Carlo simulation. The simulation identified the frequency of low-affinity ligand encounters with bound LecA and the bound LecA’s retention of the low-affinity ligand as essential parameters for triggering hetero-multivalent binding, agreeing with experimental observations. The hetero-multivalency can alter lectin binding properties, including avidities, capacities, and kinetics, and therefore, it likely occurs in various multivalent binding systems. Using hetero-multivalency concept, we also offered a new strategy to design high-affinity drug carriers for targeted drug delivery.

24 February 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
RGRichard S. Gunasekera
Richard S. Gunasekera
TGThushara Galbadage
Thushara Galbadage
CACiceron Ayala-Orozco
Ciceron Ayala-Orozco
DLDongdong Liu
Dongdong Liu
VGVictor García-López
Victor García-López
JTJames Tour
James Tour
Light-activated molecular nanomachines (MNMs) can be used to drill holes into prokaryotic (bacterial) cell walls and the membrane of eukaryotic cells, including mammalian cancer cells, by their fast rotational movement, leading to cell death. We examined how these MNMs function in multicellular organisms and investigated their use for treatment and eradication of specific diseases by causing damage to certain tissues and small organisms. Three model eukaryotic species, Caenorhabditis elegans, Daphnia pulex, and Mus musculus (mouse), were evaluated. These organisms were exposed to light-activated fast-rotating MNMs and their physiological and pathological changes were studied in detail. Slow rotating MNMs were used to control for the effects of rotation rate. We demonstrate that fast-rotating MNMs caused depigmentation and 70% mortality in C. elegans while reducing the movement as well as heart rate and causing tissue damage in Daphnia. Topically applied light-activated MNMs on mouse skin caused ulceration and microlesions in the epithelial tissue, allowing MNMs to localize into deeper epidermal tissue. Overall, this study shows that the nanomechanical action of light-activated MNMs is effective against multicellular organisms, disrupting cell membranes and damaging tissue in vivo. Customized MNMs that target specific tissues for therapy combined with spatial and temporal control could have broad clinical applications in a variety of benign and malignant disease states including treatment of cancer, parasites, bacteria, and diseased tissues.